Researchers
Veljković, Nevena
Results 101-120 of 135
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2012 | Assessment of Hepatitis C Virus Protein Sequences with Regard to Interferon/Ribavirin Combination Therapy Response in Patients with HCV Genotype 1b![]() | Glišić, Sanja | Article | 23M23 |
| 2012 | Bioinformatics approach to protein-protein interactions of WT1 isoforms | Gemović, Branislava S. | Conference Paper | Mp. category will be shown later |
| 2012 | 3D-QSAR and Virtual Docking Study of Agonists and Antagonists at Imidazoline-1 Receptor | Agbaba, Danica | Conference Paper | Mp. category will be shown later |
| 2012 | Analyses of gene variations in coding regions of molecular markers in myeloid neoplasms: web-application for TET2 gene | Veljković, Nevena V. | Conference Paper | Mp. category will be shown later |
| 2012 | Bioinformatics prediction of functional effects of CXC ligand 16 (CXCL16) gene polymorphisms I123T and A181V | Živković, Maja D. | Conference Paper | Mp. category will be shown later |
| 2012 | Identification of estrogen responsive element in the human immunodeficiency virus (type 1) long terminal repeat | Radosevic, D. | Conference Paper | Mp. category will be shown later |
| 2011 | The role of long-range intermolecular interactions in discovery of new drugs | Veljković, Nevena V. | Reviews | 22M22 |
| 2011 | Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer? | Veljković, Milena; Branch, Donald R.; Dopsaj, Violeta; Veljković, Veljko | Article | 22M22 |
| 2011 | A Bioinformatics Approach to Identify Natural Autoantibodies from Healthy Blood Donors Sera Reactive with the HCV NS5A-Derived Peptide by Immunoassay | Vasiljevic, Nada; Veljković, Nevena V. | Article | 22M22 |
| 2011 | Physical Activity and Natural Anti-VIP Antibodies: Potential Role in Breast and Prostate Cancer Therapy | Veljković, Milena; Dopsaj, Violeta | Article | 21aM21a |
| 2011 | Simple theoretical criterion for selection of candidate HIV drugs | Veljković, Nevena V. | Conference Paper | Mp. category will be shown later |
| 2010 | Selection of Ns5a-Derived Peptides for Determination of Hcv Genotypes By Serotyping | Vasiljevic, N.; Veljković, Nevena V. | Conference Paper | Mp. category will be shown later |
| 2010 | Physical activity against HIV disease, breast and prostate cancer: insights from the vasoactive intestinal peptide (VIP) based molecular mechanism | Veljković, Nevena V. | Conference Paper | Mp. category will be shown later |
| 2010 | Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: Insights from molecular dynamics simulations and the informational spectrum method | Tintori, Cristina; Veljković, Nevena V. | Article | 21M21 |
| 2009 | Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control | Veljković, Veljko | Article | 21M21 |
| 2009 | 14-3-3 Ligand Prevents Nuclear Import of c-ABL Protein in Chronic Myeloid Leukemia | Mancini, Manuela; Veljković, Nevena V. | Article | 21M21 |
| 2009 | Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor | Veljković, Veljko | Article | 21M21 |
| 2008 | AIDS vaccine: Efficacy, safety and ethics | Veljković, Veljko | Article | 21a+M21a+ |
| 2008 | EMILINs Interact with Anthrax Protective Antigen and Inhibit Toxin Action in Vitro![]() | Doliana, Roberto; Veljković, Veljko | Article | 21M21 |
| 2008 | IPO-trimethylation of histone H3-lysine(9) associated with P210BCR-ABL tyrosine kinase of chronic myeloid leukaemia | Mancini, Manuela; Zuffa, Elisa; Veljković, Nevena V. | Contribution to periodical | 21M21 |
